Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Roche Diabetes Care...

    Roche Diabetes Care India appoints Gaurav Laroia as General Manager

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-03T09:30:51+05:30  |  Updated On 3 Jan 2019 9:30 AM IST
    Roche Diabetes Care India appoints Gaurav Laroia as General Manager

    Gaurav Laroia holds a PhD in molecular and cellular biology from New York University School of Medicine, USA and a masters in genetics from the University of Cambridge, UK.


    New Delhi: Roche Diabetes Care India Wednesday said it has appointed Gaurav Laroia as general manager (GM) for its India operations.


    He will report to Roche Diabetes Care Asia Pacific head, Pedro Goncalves, and will be a member of the Roche Diabetes Care Asia Pacific leadership team, the company said in a statement.




    Laroia relocates to Mumbai from his current role as head of the program management office, APAC for Roche Pharmaceuticals in Singapore, it added.


    He has more than 18 years of experience in commercial operations, business development and management consulting in healthcare-related multinational organisations in India, Singapore and the USA, the release said.


    Gaurav holds a PhD in molecular and cellular biology from New York University School of Medicine, USA and a masters in genetics from the University of Cambridge, UK.


    "India is a very important market for Roche and our aspiration in the near future will be to be India's topmost integrated diabetes solutions provider, touching millions of lives who need smart solutions for diabetes," Laroia said.


    Also Read: Roche Diabetes Care eyes 51 per cent market share in India by 2019
    diabetesdr Gaurav LaroiaGaurav LaroiaGeneticsHealthcareIndiaNew DelhiNew York University School of MedicinePedro GoncalvesRocheRoche Diabetes CareRoche Diabetes Care IndiaRoche PharmaceuticalsUniversity of CambridgeUSA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok